About the Authors

Konstantinos A. Polyzos

Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece

Michael N. Mavros

Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece

Konstantinos Z. Vardakas

Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece

Marinos C. Makris

Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece

Petros I. Rafailidis

Affiliations Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece, Department of Medicine, Henry Dunant Hospital, Athens, Greece

Matthew E. Falagas

m.falagas@aibs.gr

Affiliations Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece, Department of Medicine, Henry Dunant Hospital, Athens, Greece, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America

Competing Interests

MEF has participated on the advisory boards of Astellas, Bayer, and Pfizer and has received lecture honoraria from Astellas, AstraZeneca, Cipla, Glenmark, Merck, Novartis, and Pfizer. All other authors report no potential conflicts.

Author Contributions

Analyzed the data: KAP MNM KZV MCM PIR MEF. Wrote the paper: KAP MEF. Designed the study: KAP MEF. Collected the data: KAP MNM MCM. Revised the manuscript: KAP MNM KZV MCM PIR MEF. Approved the final version of the manuscript: KAP MNM KZV MCM PIR MEF.